Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP504964.RAGlRrDn2jA9UBxCcSGpN4OB-IeQrdP4MoGzqMK7sQFI8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP504964.RAGlRrDn2jA9UBxCcSGpN4OB-IeQrdP4MoGzqMK7sQFI8130_assertion type Assertion NP504964.RAGlRrDn2jA9UBxCcSGpN4OB-IeQrdP4MoGzqMK7sQFI8130_head.
- NP504964.RAGlRrDn2jA9UBxCcSGpN4OB-IeQrdP4MoGzqMK7sQFI8130_assertion description "[The importance of achieving a very good partial response or better (?VGPR) after induction treatment of myeloma has traditionally only been discussed in the context of high-dose therapy with auto-SCT (HDT/auto-SCT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP504964.RAGlRrDn2jA9UBxCcSGpN4OB-IeQrdP4MoGzqMK7sQFI8130_provenance.
- NP504964.RAGlRrDn2jA9UBxCcSGpN4OB-IeQrdP4MoGzqMK7sQFI8130_assertion evidence source_evidence_literature NP504964.RAGlRrDn2jA9UBxCcSGpN4OB-IeQrdP4MoGzqMK7sQFI8130_provenance.
- NP504964.RAGlRrDn2jA9UBxCcSGpN4OB-IeQrdP4MoGzqMK7sQFI8130_assertion SIO_000772 20154737 NP504964.RAGlRrDn2jA9UBxCcSGpN4OB-IeQrdP4MoGzqMK7sQFI8130_provenance.
- NP504964.RAGlRrDn2jA9UBxCcSGpN4OB-IeQrdP4MoGzqMK7sQFI8130_assertion wasDerivedFrom befree-20140225 NP504964.RAGlRrDn2jA9UBxCcSGpN4OB-IeQrdP4MoGzqMK7sQFI8130_provenance.
- NP504964.RAGlRrDn2jA9UBxCcSGpN4OB-IeQrdP4MoGzqMK7sQFI8130_assertion wasGeneratedBy ECO_0000203 NP504964.RAGlRrDn2jA9UBxCcSGpN4OB-IeQrdP4MoGzqMK7sQFI8130_provenance.